Fate Therapeutics (FATE) announced the appointment of Kamal Adawi, M.S., M.B.A., to the role of Chief Financial Officer, CFO, effective October 20, 2025. Adawi brings to the Company more than 20 years of financial leadership experience in the life sciences industry.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.